Get started
Author

Luca Montemurro

Observed names: L Montemurro, Montemurro, Luca, Montemurro, Luca Antonio <1977>
ORCID: 0000-0002-3802-0846
Observed ORCID: 0000-0002-3802-0846
OpenAlex ID: A5087477159
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
2022 · Damiano Bartolucci, Luca Montemurro, et al. · Cancers · 70
PDF
MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma
2021 · Salvatore Raieli, Daniele Di Renzo, et al. · Frontiers in Oncology · 45
PDF
MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte–macrophage maturation in AML-M5 THP-1 cells
2003 · Andrea Pession, Vincenzo Martino, et al. · Oncogene · 42
A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma
2019 · Luca Montemurro, Salvatore Raieli, et al. · Cancer Research · 39
PDF
MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia
2013 · Annalisa Astolfi, Francesca Vendemini, et al. · Oncotarget · 33
PDF
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
2022 · Silvia Lampis, Salvatore Raieli, et al. · Journal of Experimental & Clinical Cancer Research · 28
PDF
ArgBP2, encoding a negative regulator of ABL, is fused to MLL in a case of infant M5 acute myeloid leukemia involving 4q35 and 11q23
2006 · A Pession, L Lo Nigro, et al. · Leukemia · 12
Down-regulation of MLL-AF9, MLL and MYC expression is not obligatory for monocyte-macrophage maturation in AML-M5 cell lines carrying t(9;11)(p22;q23)
2006 · Vincenzo Martino, Roberto Tonelli, et al. · Oncology Reports · 10
Preclinical Pharmacokinetics in Tumors and Normal Tissues of the Antigene PNA Oligonucleotide MYCN-Inhibitor BGA002
2024 · Anna Lisa Scardovi, Damiano Bartolucci, et al. · Nucleic Acid Therapeutics · 9
PDF
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance
2023 · Sonia Bortolotti, Silvia Angelucci, et al. · Cancers · 8
PDF
Identification of two MLL-MLLT3 (alias MLL-AF9) chimeric transcripts in the MOLM-13 cell line
2004 · Luca Montemurro, Roberto Tonelli, et al. · Cancer Genetics and Cytogenetics · 4
Supplementary Methods and Fig s1-s13 from A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma
2023 · Luca Montemurro, Salvatore Raieli, et al.
PDF
Supplementary tables from A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma
2023 · Luca Montemurro, Salvatore Raieli, et al.
Data from A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma
2023 · Luca Montemurro, Salvatore Raieli, et al.
Data from A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma
2023 · Luca Montemurro, Salvatore Raieli, et al.
Additional file 2 of The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
2022 · Lampis, Silvia, Raieli, Salvatore, et al. · Figshare
Virtual screening di inibitori del complesso N-Myc/Max e valutazioni in vitro
2008 · Montemurro, Luca Antonio <1977> · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)
Identification of a New t(4;11) Rearrangement Involving MLL and ArgBP2 in a Case of Infant Acute Myeloid Leukemia.
2004 · Roberto Tonelli, Luca Lo Nigro, et al. · Blood
Works count: 20
Citation count: 300
H-index: 9
I10-index: 8
Year
Topic
Type